Abstract

A first prototype of optical scanner based on a CCD camera and the use of Fricke-agarose-XO has allowed us to reconstruct 3D dose maps, monitoring doses in the range 0.5–3 Gy. Measurements performed with laboratory tests and with clinical beams would indicate that the uncertainty involved in dose mapping are compatible with requirements of a 3D dosimetry for the verifications of treatment plans.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.